Risk modelling for quality improvement in the critically ill: making best use of available data – RRAM study
Description
To establish the clinical and health economic effects of moving from systemic heparin anticoagulation to regional citrate anticoagulation for continuous renal replacement therapy for patients treated for acute kidney injury on non-specialist ICUs in England and Wales by linking routinely collected data sources.
Objectives:
1. Investigate the short-term benefits, risks, and costs of citrate anticoagulation.
2. Provide information on the subsequent development of end-stage renal disease (ESRD).
3. Trial the efficient research techniques, that if successful could be used to track the effects of any change in critical care practice occurring in ICUs in England and Wales over a reasonably short time scale.
UKRR data are to be used for objective 2.
Who
Doug Gould <Doug.Gould@icnarc.org> - Senior Researcher
Files
Data Sharing Agreement for UKRR DSA62 R:\0 Information Governance\Data sharing agreements (DSAs)\DSAs\Current DSAs\DSA62 Harrison_ICNARC_RRAM
Documents from IGNARC in R:\0 Systems\Projects\RRAM
Data Extract files and code in Q:\Data Sets\2019-01-10 DSA62